Table 1

Characteristics of patients undergoing isolated tricuspid valve surgery from 2004 to 2013

Total
(n=1041)
Men
(n=442)
Women
(n=599)
P value
Age, mean±SD58.9±16.858.3±17.659.4±16.20.30
Race, n (%)
 Caucasian606 (58.2)256 (57.9)350 (58.4)0.95
 African American101 (9.7)45 (10.2)56 (9.3)
 Hispanic59 (5.7)24 (5.4)35 (5.8)
Teaching hospital, n (%)892 (85.7)381 (86.2)511 (85.3)0.69
Medical comorbidity, n (%)
 Hypertension512 (49.2)201 (45.5)311 (51.9)0.04
 Diabetes208 (20.0)84 (19.0)124 (20.7)0.50
 Coronary artery disease350 (33.6)178 (40.3)172 (28.7)<0.001
 Pacemaker*/intracardiac defibrillator116 (11.1)52 (11.8)64 (10.7)0.58
 Atrial fibrillation/flutter517 (49.7)208 (47.1)309 (51.6)0.15
 Pulmonary hypertension238 (22.9)95 (21.5)143 (23.9)0.37
 Chronic kidney disease197 (18.9)105 (23.8)92 (15.4)<0.0001
 End-stage renal disease59 (5.7)34 (7.7)25 (4.2)0.02
 Cirrhosis41 (3.9)20 (4.5)21 (3.5)0.40
 Charlson comorbidity index ≥2597 (57.3)266 (60.2)331 (55.3)0.11
Prior sternotomy, n (%)130 (12.5)43 (9.7)87 (14.5)0.02
Prior valve surgery, n (%)98 (9.4)23 (5.2)75 (12.5)<0.0001
Prior CABG, n (%)34 (3.3)21 (4.8)13 (2.2)0.02
Surgical characteristics, n (%)
 TV replacement—mechanical242 (23.2)93 (21.0)149 (24.9)0.15
 TV replacement—bioprosthetic374 (35.9)162 (36.7)212 (35.4)0.68
 TV repair425 (40.8)187 (42.3)238 (39.7)0.40
 Concomitant CABG208 (20.0)112 (25.3)96 (16.0)<0.0001
  • *Permanent pacemaker.

  • CABG, coronary artery bypass graft surgery; TV, tricuspid valve.